ABT-413

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameABT-413
Drug Alias NameABT-413
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 5 modulatorsSphingosine 1-Phosphate Receptor 1 modulators
TargetsSphingosine 1-Phosphate Receptor 1Sphingosine 1-phosphate receptor 5
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A